Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1809918
Name of medicinal product: Stelfonta
Active substances:
Tigilanol tiglate
Estonian, English, Latin
ATC code: QL01XX91
Dosage form: solution for injection
Route of administration: intratumoral use
Strengh: 1mg 1ml
Amount in package: 2ml 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: For the treatment of non-resectable, non-metastatic (WHO staging) subcutaneous mast cell tumours located at or distal to the elbow or the hock, and non-resectable, non-metastatic cutaneous mast cell tumours in dogs. Tumours must be less than or equal to 8 cm3 in volume, and must be accessible to intratumoral injection.
Safety features: No
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Withdrawal time:  
Species: koer
Last imported to Estonia: 05 November 2021
Marketing authorization holder: QBiotics Netherlands B.V. 
Marketing authorization number: EU/2/19/248 
Marketing authorization issued on: 15 January 2020 
Marketing authorization expires on: 17 January 2025 
Marketing authorization procedure type: Centralised 
Entry/Changing date: 21 January 2020
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription